Kinetic Capital Partners

Kinetic Capital Partners is a private equity firm based in Vancouver, Canada. Established in 2002, the company specializes in later-stage investments, focusing on buyouts and pre-IPO companies. Its primary sectors of interest include healthcare, medical devices, software, and TMT industries within North America.

Frank Barker

Partner

Dallas H Ross

Partner

22 past transactions

Moko Yogurt

Venture Round in 2023
Moko Yogurt is a brand that focuses on various floured yogurt drinks and provides sucrose-free products.

CXIP Labs

Seed Round in 2022
CXIP Labs is a developer of NFT infrastructure solutions for the web3 ecosystem.

BlockApps

Series B in 2022
BlockApps develops an enterprise blockchain platform that enables businesses to build, deploy, and manage Ethereum-based applications. Its flagship product, BlockApps STRATO, facilitates the creation of hybrid private, consortium, and public blockchains. The company serves software startups, IT firms, industry-owned businesses, and Fortune 500 corporations.

World

Venture Round in 2021
World is a technology company specializing in secure digital asset management. It operates the World App, which enables users to securely store their World ID, manage digital assets, and access various Mini Apps within a privacy-focused network.

Dtravel

Seed Round in 2021
Dtravel is a decentralized platform for the home-sharing economy that supports short- and long-term stays and accepts cryptocurrency alongside traditional payment methods. It operates without intermediaries by returning ownership, control and decision-making to hosts and guests through blockchain technology, promoting transparency and reducing fees in the home rental market. The platform aims to empower guests to shape their travel experiences while maintaining community transparency and trust.

Jet Protocol

Seed Round in 2021
Jet Protocol Holdings is a developer of a decentralized lending and borrowing platform that aims to reduce transaction costs and enhance efficiency in financial transactions. The company specializes in creating innovative loan products and facilitates cross-chain interest rate arbitrage, allowing users to streamline their borrowing and lending activities. Through its platform, Jet Protocol Holdings provides a borrowing agreement designed to simplify the complexities often associated with traditional financial systems, making it easier for users to engage in lending and borrowing transactions.

Flare Network

Venture Round in 2021
Flare Networks is a blockchain network that utilizes the Flare Consensus Protocol, which is the first Turing Complete Federated Byzantine Agreement protocol. It offers a decentralized contract platform aimed at enhancing contract capabilities across various blockchains. By leveraging the Ethereum Virtual Machine, Flare Networks can access and utilize information from other blockchains and real-world data sources, effectively addressing the oracle problem. This functionality facilitates cross-chain interoperability, allowing users to share contract capabilities with different protocols. Flare Networks seeks to enable a new era of utility within the blockchain ecosystem through its innovative technology.

SubDAO Network

Funding Round in 2021
SubDAO Network is a platform facilitating the creation and management of Decentralized Autonomous Organizations (DAOs). Built on Polkadot, it connects DAOs with DApps for cross-chain management and bridges Web 2.0 and Web 3.0.

Convergence Finance

Seed Round in 2021
Convergence Finance operates as a decentralized interchangeable asset protocol focused on facilitating the exchange of tokenized real-world assets. By leveraging blockchain technology and smart contracts, the company has developed a decentralized exchange platform that employs an automated market maker model. This innovative approach aims to enhance liquidity for tokenized assets, thereby transforming trading practices for both real-world and crypto-native investments. Convergence Finance prioritizes greater transparency and inclusivity, making it easier for all investors to access and trade these assets.

Terra

Venture Round in 2021
Terra is a price-stable cryptocurrency designed for mass adoption. It builds financial infrastructure for the next generation of decentralized applications. Terra is backed by Luna, a decentralized asset that derives its value from transaction fees collected on the Terra network. Much like the moon stabilizes the earth’s rotation, Luna is Terra's eternal guardian of stability.

CERE Network

Venture Round in 2021
CERE Network is a blockchain-based company that specializes in developing a customer relationship management (CRM) ecosystem designed for data integration and collaboration. Founded in 2019 and headquartered in San Francisco, California, CERE Network offers a platform that extracts customer data from various monolithic and disparate CRM and customer data platform systems. This platform provides an open micro-services environment that facilitates data collaboration and integration between businesses and vendors. Additionally, CERE Network utilizes blockchain technology to capture the entire customer journey, securely storing key user data such as purchases and achievements in user wallets. The company also introduces its own tokens, which are used for payment within its ecosystem.

Orange Schade

Seed Round in 2020
Orange Schade is a versatile company that specializes in auto body repair services and vehicle leasing solutions. It offers a comprehensive range of services, including damage repair recognized by Opel, car damage repair in Orange, and replacement vehicle services. The company has established a robust network of auto body repair shops, which enhances its ability to provide efficient and effective solutions for its customers. In addition, Orange Schade operates Special Lease, a leasing division that provides rental services, lease forms, and related offerings. With a focus on competitive pricing and high-quality service, the company tailors its lease terms to meet the diverse needs of its clientele, drawing on extensive experience in finance and insurance to support its operations.

Reef Finance

Seed Round in 2020
Reef Finance LLC is a decentralized finance platform that operates on the Polkadot blockchain. Founded in 2019 by CEO Denko Mancheski, the company is headquartered in Wilmington, Delaware. Reef Finance specializes in providing a liquidity aggregator and yield engine, facilitating trading by connecting users to liquidity from both centralized and decentralized exchanges. Its services include smart lending, borrowing, staking, and mining, all enhanced by an AI-driven personalized yield engine. As a pioneer in the Polkadot ecosystem, Reef Finance was notably the first project launched on Binance Launchpool, solidifying its position in the DeFi landscape.

Linear Finance

Seed Round in 2020
Linear Finance is a company that operates a decentralized delta-one asset protocol designed for cross-chain compatibility, facilitating the creation, management, and trading of synthetic assets with unlimited liquidity. The company serves various sectors, including cryptocurrency, commodities like crude oil and coffee, market indices, e-sports, and sustainability. Headquartered in New Territories, Hong Kong, Linear Finance leverages a blend of technical expertise from the cryptocurrency space and financial acumen from traditional asset management, enabling users to engage with assets efficiently and at fair market value.

ThunderCore

Series A in 2019
ThunderCore operates a high-performance public blockchain compatible with the Ethereum Virtual Machine (EVM). It employs a proprietary consensus protocol called PaLa, which addresses scalability challenges and enables rapid transaction processing at over 4,000 TPS with confirmation times under one second. The network's native currency, TT, facilitates secure and low-cost transactions, with gas fees costing less than a fraction of a cent. ThunderCore serves an international user base across over 190 countries, supporting decentralized applications (dApps) with enhanced security and scalability.

Eximchain

Initial Coin Offering in 2018
Eximchain is a global sourcing platform designed for small-to-medium sized businesses. It offers data-driven analysis, customized supplier recommendations, direct connections with suppliers, and a reputation system based on transaction history. The platform also digitizes contracts and proof of performance, storing them securely on the blockchain.

Bluzelle

Initial Coin Offering in 2018
Bluzelle is a developer of a blockchain database aimed at addressing data storage and management challenges for decentralized applications. The company provides a comprehensive stack of blockchain applications, middleware, and data services tailored to meet the needs of a diverse clientele, from small and medium enterprises to global corporations. Its database solution features multi-region coverage and enhanced network security, ensuring scalability while minimizing environmental impact. Bluzelle's offerings enable developers to maintain up-to-date data that is both secure from hacking attempts and resistant to censorship, making it a valuable resource for businesses seeking innovative data management solutions.

Viscardia

Series B in 2017
Viscardia develops and commercializes a medical device therapy for patients with heart failure. Its fully implantable system uses electrical stimulation to engage the patient's own thoracic musculature, improving cardiac filling and output.

Protiva Biotherapeutics

Venture Round in 2007
Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.

U-Systems

Venture Round in 2007
U-Systems is a developer and manufacturer of advanced ultrasound systems and software specifically designed to assist radiologists in the detection of breast cancer, particularly in women with dense breast tissue. The company’s innovative breast ultrasound systems produce 3D images that enhance visualization of targeted areas of concern within the breast. In addition to its focus on breast cancer diagnostics, U-Systems also designs and manufactures high-quality racking enclosures and cooling products aimed at reducing noise, heat, and costs in data centers and offices, utilizing innovative design principles and state-of-the-art manufacturing processes.

AgInfoLink

Series A in 2007
AgInfoLink Inc. designs and develops traceability solutions for the food industry. It offers data collection, secure data transmission, data warehousing, reporting, and analysis tools for linking information for individual animal management, regulatory compliance, and business performance. The company provides Pony Express, a data sharing solution to create and customize a data sharing network for supply chain; BeefLink, a personal computer-based data collection and management system to capture and store data automatically from RFID and barcode tags, scales, and other devices; AgInfoReports and AgInfoSheets reporting systems; and AgMobile, a handheld unit and wireless RFID reader that allows livestock producers to identify animals, record data, and reference historical data. AgInfoLink, Inc. also offers CattleCard, a data collection solution, for customers without computers, to collect group data and individual data using a barcode label sticker and RFID identifier; Tag Tracker, a rugged hand-held wireless RFID reader reads an RFID tag and communicates with a base station; and Animal Logger, a solution for collecting NAIS required and basic animal movement information, as well as WebReporting and Decision Pro tools, and processed verification programs. It serves state regulators, meat processors, retail/foodservice, and livestock producers. The company was founded in 1997 and is based in Longmont, Colorado.

Protiva Biotherapeutics

Series C in 2006
Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.